Tower Research Capital (TRC)’s Global Cord Blood Corporation CO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-457
| Closed | -$2K | – | 7095 |
|
|
2022
Q1 | $2K | Buy |
+457
| New | +$1.9K | ﹤0.01% | 5727 |
|
|
2021
Q1 | – | Sell |
-2,137
| Closed | -$8K | – | 6061 |
|
|
2020
Q4 | $8K | Buy |
+2,137
| New | +$8.2K | ﹤0.01% | 4469 |
|
|
2020
Q3 | – | Sell |
-512
| Closed | -$2K | – | 5360 |
|
|
2020
Q2 | $2K | Sell |
512
-792
| -61% | -$2.3K | ﹤0.01% | 4575 |
|
|
2020
Q1 | $4K | Buy |
1,304
+135
| +12% | +$590 | ﹤0.01% | 2431 |
|
|
2019
Q4 | $6K | Sell |
1,169
-297
| -20% | -$1.42K | ﹤0.01% | 2659 |
|
|
2019
Q3 | $7K | Buy |
1,466
+1,426
| +3,565% | +$7.48K | ﹤0.01% | 3188 |
|
|
2019
Q2 | $0 | Buy |
+40
| New | +$264 | ﹤0.01% | 4739 |
|
|
2019
Q1 | – | Sell |
-45
| Closed | – | – | 4724 |
|
|
2018
Q4 | $0 | Sell |
45
-3,385
| -99% | -$21.6K | ﹤0.01% | 4786 |
|
|
2018
Q3 | $24K | Buy |
+3,430
| New | +$25.8K | ﹤0.01% | 2231 |
|
|
2018
Q2 | – | Sell |
-12,934
| Closed | -$132K | – | 4439 |
|
|
2018
Q1 | $132K | Buy |
+12,934
| New | +$132K | 0.01% | 1093 |
|
|
2017
Q4 | – | Sell |
-5,869
| Closed | -$65K | – | 4407 |
|
|
2017
Q3 | $65K | Buy |
+5,869
| New | +$68.7K | 0.01% | 1752 |
|
|
2017
Q2 | – | Sell |
-1,141
| Closed | -$8K | – | 3923 |
|
|
2017
Q1 | $8K | Buy |
1,141
+945
| +482% | +$5.6K | ﹤0.01% | 1959 |
|
|
2016
Q4 | $1K | Sell |
196
-4,330
| -96% | -$21.6K | ﹤0.01% | 3733 |
|
|
2016
Q3 | $23K | Buy |
4,526
+3,790
| +515% | +$20.2K | ﹤0.01% | 1539 |
|
|
2016
Q2 | $4K | Buy |
736
+316
| +75% | +$1.92K | ﹤0.01% | 3606 |
|
|
2016
Q1 | $3K | Buy |
420
+175
| +71% | +$1.04K | ﹤0.01% | 3239 |
|
|
2015
Q4 | $2K | Buy |
+245
| New | +$1.55K | ﹤0.01% | 3915 |
|
|
2015
Q3 | – | Sell |
-1,051
| Closed | -$6K | – | 5251 |
|
|
2015
Q2 | $6K | Buy |
1,051
+751
| +250% | +$4.61K | ﹤0.01% | 3184 |
|
|
2015
Q1 | $2K | Buy |
+300
| New | +$1.48K | ﹤0.01% | 3909 |
|
|
2014
Q4 | – | Sell |
-2,837
| Closed | -$14K | – | 5120 |
|
|
2014
Q3 | $14K | Buy |
2,837
+2,250
| +383% | +$10.9K | ﹤0.01% | 2614 |
|
|
2014
Q2 | $3K | Buy |
587
+430
| +274% | +$1.93K | ﹤0.01% | 3289 |
|
|
2014
Q1 | $1K | Buy |
+157
| New | +$638 | ﹤0.01% | 4282 |
|
|
2013
Q3 | – | Sell |
-200
| Closed | -$1K | – | 5041 |
|
|
2013
Q2 | $1K | Buy |
+200
| New | +$571 | ﹤0.01% | 3799 |
|
Other funds holding CO
OMC
BCM
QOP
FCM
BFM
Tower Research Capital (TRC)'s CO Position: Q2 2022 in Review
Tower Research Capital (TRC) sold out of Global Cord Blood Corporation (CO) in Q2 2022, closing a stake of 457 shares — an estimated $2K sold.
Tower Research Capital (TRC) first reported a position in CO in Q2 2013 and held it in 23 quarters. The position peaked at $132K in Q1 2018. 25 funds tracked by Wall St. Rank hold CO as of Q2 2022.
- Tower Research Capital (TRC) reported no remaining Global Cord Blood Corporation position as of Q2 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 457 Global Cord Blood Corporation shares in Q2 2022, an estimated $2K.
- Tower Research Capital (TRC) first reported a position in Global Cord Blood Corporation in Q2 2013 and held it in 23 quarters.
- Tower Research Capital (TRC)'s Global Cord Blood Corporation position peaked at $132K in Q1 2018.
- 25 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.